Inhibition of CSF-1 R inhibits rebound of ERK in BRAF-treated melanoma, shifting the TME toward a pro-inflammatory state with subsequent reduction in growth and invasiveness of melanoma cells [130]. Here, BRAF is linked to melanoma.